Circulating angiogenic factors and the risk of preeclampsia

Levine, Richard J., Maynard, Sharon E., Qian, Cong, Lim, Kee-Hak, England, Lucinda J., Yu, Kai F., Schisterman, Enrique F., Thadhani, Ravi +5 more·2004·New England Journal of Medicine
DOI 10.1056/nejmoa031884

Cited by (1,011)

Items 701–800 of 1,011

  1. Circulating Angiogenic Modulatory Factors Predict Survival and Functional Class in Pulmonary Arterial Hypertension
    Rajeev Kumar Malhotra, Samuel D Paskin-Flerlage, Roham T. Zamanian, Patrick Zimmerman, Jonathan W. Schmidt, Donna Y. Deng, Mark R. Southwood, Robert Spencer, Carol S. C. Lai, William Parker et al. · 2013 · Pulmonary Circulation
  2. Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology?
    Anne Q. Reuwer, Patrycja M. Nowak-Sliwinska, Laurie A. Mans, Chris M. van der Loos, Jan H. von der Thüsen, Marcel Twickler, C. Arnold Spek, Vincent Goffin, Arjan W. Griffioen, Keren Borensztajn · 2011 · Journal of Cellular and Molecular Medicine
  3. Tumor necrosis factor α induces a model of preeclampsia in pregnant baboons (Papio hamadryas)
    Neroli Sunderland, Sally E. Thomson, Scott J. Heffernan, Shirlene M. Lim, John F. Thompson, Robert F. Ogle, Paul R. McKenzie, Paul J. Kirwan, Angela Makris, Annemarie Hennessy · 2011 · Cytokine
  4. Possible Common Aetiology behind Maternal Preeclampsia and Congenital Heart Defects in the Child: a Cardiovascular Diseases in N orway Project Study
    Kristoffer Brodwall, Elisabeth Leirgul, Gottfried Greve, Stein Emil Vollset, Henrik Holmstrøm, Grethe Seppola Tell, Nina Øyen · 2015 · Paediatric and Perinatal Epidemiology
  5. Metabolic disorder of pregnancy (understanding pathophysiology of diabetes and preeclampsia).
    Liat Salzer, K. Tenenbaum-Gavish, M. Hod · 2015 · Best Practice & Research: Clinical Obstetrics & Gynaecology
  6. Imbalance between matrix metalloproteinases and their tissue inhibitors in preeclampsia and gestational trophoblastic diseases
    Beenish Rahat, Renuka Sharma, Rashmi Bagga, Abid Hamid, Jyotdeep Kaur · 2016 · Reproduction
  7. Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response
    Andrea Balogh, Eszter Toth, Roberto J. Romero, Katalin Paréj, Diana Csala, Nikolett L. Szenasi, István Hajdú, Kata Juhász, Árpád Ferenc Kovács, Hamutal Meiri et al. · 2019 · Frontiers in Immunology
  8. Prolylcarboxypeptidase gene, chronic hypertension, and risk of preeclampsia
    Lin Wang, Yan Feng, Yan Zhang, Huanyu Zhou, Shanqun Jiang, Tianhua Niu, L. J. Wei, Xin Ping Xu, Xiping Xu, Xiaobin Wang · 2006 · American Journal of Obstetrics and Gynecology
  9. Preeclampsia and Obesity—The Preventive Role of Exercise
    Elżbieta Poniedziałek‐Czajkowska, Radzisław Mierzyński, Bożena Leszczyńska‐Gorzelak · 2023 · International Journal of Environmental Research and Public Health
  10. Clinical Evaluation and Management of Thrombotic Microangiopathy
    Joshua M. Leisring, Sergey V. Brodsky, Samir V. Parikh · 2023 · Arthritis & Rheumatology
  11. Blood protein profiles of infants born before 28 weeks differ by pregnancy complication
    Thomas Frederick McElrath, Raina Nakova Fichorova, Elizabeth N. Allred, Jonathan L. Hecht, Mahmoud Ismail, Huaiping Yuan, Alan Leviton · 2011 · American Journal of Obstetrics and Gynecology
  12. Gestational Diabetes and Hypertensive Disorders of Pregnancy as Vascular Risk Signals: An Overview and Grading of the Evidence
    Kara A. Nerenberg, Stella Styliani Daskalopoulou, Kaberi Dasgupta · 2014 · Canadian Journal of Cardiology
  13. The developmental role of natural killer cells at the fetal-maternal interface
    Simcha Yagel · 2009 · American Journal of Obstetrics and Gynecology
  14. Controversies With the Diagnosis and Management of HELLP Syndrome
    John O’Brien, John R. Barton · 2005 · Clinical Obstetrics & Gynecology
  15. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study
    Roberto J. Romero, Tinnakorn Chaiworapongsa, Offer Erez, Adi Laurentiu Tarca, Maria Teresa Gervasi, Juan Pedro Kusanovic, Pooja Mittal, Giovanna Oggè, Edi Vaisbuch, Shali Mazaki‐Tovi et al. · 2010 · The Journal of Maternal-Fetal & Neonatal Medicine
  16. Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy
    Laura Ham Benschop, Sarah Schalekamp–Timmermans, Zoe A. Broere-Brown, Jeanine E. Roeters van Lennep, Vincent W. V. Jaddoe, Jolien W. Roos‐Hesselink, M. Kamran Ikram, Eric A.P. Steegers, James Michael Roberts, Robin E. Gandley · 2019 · Circulation
  17. Second‐trimester uterine artery Doppler pulsatility index and maternal serum PP13 as markers of pre‐eclampsia
    Kevin Spencer, Nicholas J. Cowans, Ilana Chefetz, Joseph Tal, Ido Kuhnreich, Hamutal Meiri · 2007 · Prenatal Diagnosis
  18. Etiopathogenesis, prediction, and prevention of preeclampsia
    P. J. Correa, Yasna K. Palmeiro-Silva, M. J. Soto, C. Marin De Ugarte, Sebastian Enrique Illanes · 2016 · Hypertension in Pregnancy
  19. Maternal Stroke
    Islam Y. Elgendy, Syed Bukhari, Amr F. Barakat, Carl J. Pepine, Kathryn J. Lindley, Eliza C. Miller · 2021 · Circulation
  20. Epigenetics and microRNAs in Preeclampsia
    Mahua Choudhury, Jacob E. Friedman · 2012 · Clinical and Experimental Hypertension
  21. Reduced uterine perfusion pressure induces hypertension in the pregnant mouse
    Suttira Intapad, Junie Paula Warrington, Frank Travis Spradley, Ana Carolina Palei, Heather A. Drummond, Michael James Ryan, Joey P. Granger, Barbara T. Alexander · 2014 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  22. Fetal ERAP2 variation is associated with preeclampsia in African Americans in a case-control study
    Lori D. Hill, DaShaunda D. Hilliard, Timothy P. York, Sindhu Kikkeri Srinivas, Juan Pedro Kusanovic, Ricardo Gómez, Michal A. Elovitz, Roberto J. Romero, Jerome F. Strauss · 2011 · BMC Medical Genetics
  23. Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre‐eclampsia
    Jun‐Ma Yu, Chenzi Shixia, Yanming Wu, Tao Duan · 2010 · Ultrasound in Obstetrics and Gynecology
  24. Vascular endothelial growth factor gene +936 C/T polymorphism is associated with preeclampsia in Korean women
    Jae‐Yoon Shim, Jong Kwan Jun, Bok‐Kyung Jung, Sung Hoon Kim, Hye‐Sung Won, Pil Ryang Lee, Ahm Kim · 2007 · American Journal of Obstetrics and Gynecology
  25. Angiogenic and Fibrinolytic Factors in Blood During the First Half of Pregnancy and Adverse Pregnancy Outcomes
    Marianne Coolman, Sarah Timmermans, Christianne J.M. de Groot, Henk Russcher, Jan Willem Lindemans, Albert Hofman D, Anneke J Geurts-Moespot, Fred C.G.J. Sweep, Vincent V. W. Jaddoe, Eric A.P. Steegers · 2012 · Obstetrics and Gynecology
  26. Glial Cell Missing 1 Regulates Placental Growth Factor (PGF) Gene Transcription in Human Trophoblast1
    Miao Chang, Debashree Mukherjea, Ryan M. Gobble, Kathleen A. Groesch, Ronald J. Torry, Donald S. Torry · 2007 · Biology of Reproduction
  27. The impact of periconceptional maternal lifestyle on clinical features and biomarkers of placental development and function: a systematic review
    Igna F. Reijnders, Annemarie G. M. G. J. Mulders, Melissa van der Windt, Eric A.P. Steegers, Régine P.M. Steegers‐Theunissen · 2018 · Human Reproduction Update
  28. Prediction of imminent preeclampsia at 35–37 weeks gestation
    Anca Marina Ciobanu, Alan Wright, Anca Maria Panaitescu, Argyro Syngelaki, David E. Wright, Kypros H. Nicolaides · 2019 · American Journal of Obstetrics and Gynecology
  29. Human Chorionic Villous Differentiation and Placental Development
    Junya Kojima, Masanori Ono, Naoaki Kuji, Hirotaka Nishi · 2022 · International Journal of Molecular Sciences
  30. Placental cytokines and preeclampsia
    Jeffrey A. Keelan · 2006 · Frontiers in bioscience
  31. Angiogenic targets for potential disorders
    Shraddha V. Bhadada, Bhoomika R. Goyal, Bhoomika M. Patel · 2010 · Fundamental and Clinical Pharmacology
  32. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia
    Hiroyuki Seki · 2014 · Acta Obstetricia Et Gynecologica Scandinavica
  33. Innate Immunity, Decidual Cells, and Preeclampsia
    Chang-Ching Yeh, Kuan-Chong Chao, Se-Te Joseph Huang · 2012 · Reproductive Sciences
  34. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia
    Anna‐Karin Wikström, Peppi Nash, Ulf J. Eriksson, Matts H. Olovsson · 2009 · American Journal of Obstetrics and Gynecology
  35. Circulating Angiogenic Factors and Urinary Prolactin as Predictors of Adverse Outcomes in Women With Preeclampsia
    Alfredo Leaños‐Miranda, Inova Campos-Galicia, Karla Leticia Ramírez-Valenzuela, Zarela Lizbeth Chinolla-Arellano, Irma Isordia‐Salas · 2013 · Hypertension
  36. Effect of Antihypertensive Therapy with Alpha Methyldopa on Levels of Angiogenic Factors in Pregnancies with Hypertensive Disorders
    Asma A. Khalil, Shanthi Muttukrishna, Kevin Harrington, Eric R. M. Jauniaux · 2008 · PLoS ONE
  37. Angiogenesis and chronic kidney disease
    Yohei Maeshima, Hirofumi Makino · 2010 · Fibrogenesis & Tissue Repair
  38. Autocrine activity of soluble Flt-1 controls endothelial cell function and angiogenesis
    Shakil Ahmad, Peter W. Hewett, Bahjat Al‐Ani, Samir Sissaoui, Takeshi Fujisawa, Melissa Cudmore, Asif Ahmed · 2011 · Vascular Cell
  39. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage
    Claire DE MOREUIL, Zarrin Alavi, Élisabeth Pasquier · 2019 · British Journal of Clinical Pharmacology
  40. Novel Soluble Flt-1 Isoforms in Plasma and Cultured Placental Explants from Normotensive Pregnant and Preeclamptic Women
    Augustine Rajakumar, Robert W. Powers, Carl A. Hubel, Eiji Shibata, Frauke von Versen‐Höynck, Daniel A. Plymire, Arun Jeyabalan · 2008 · Placenta
  41. Establishing Reference Values for Both Total Soluble Fms-Like Tyrosine Kinase 1 and Free Placental Growth Factor in Pregnant Women
    Chikako Hirashima, Akihide Ohkuchi, Fujimi Arai, Kayo Takahashi, Hirotada Suzuki, Takashi Watanabe, Kazuomi Kario, Shigeki Matsubara, Mitsuaki Suzuki · 2005 · Hypertension Research
  42. In Vitro and In Vivo Evidence for Lack of Endovascular Remodeling by Third Trimester Trophoblasts
    Satyan S. Kalkunte, Z. Lai, Neetu Tewari, C.O. Chichester, Roberto J. Romero, James F. Padbury, Surendra Sharma · 2008 · Placenta
  43. Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole
    Kaori Koga, Yutaka Osuga, Toshiki Tajima, Yasushi Hirota, Toshio M. Igarashi, Tomoyuki Fujii, Tetsu Yano, Yuji Taketani · 2009 · Fertility and Sterility
  44. Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague–Dawley rats
    Shamal Ramesar, Irene Mackraj, Prem Gathiram, Jagidesa Moodley · 2011 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  45. Role of Biomarkers in Early Detection of Preeclampsia
    Manisha Kar · 2014 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
  46. Innate Immune System at the Maternal–Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes
    Paola Triggianese, Carlo Perricone, Maria Sole Chimenti, Caterina De Carolis, Roberto Perricone · 2016 · American Journal of Reproductive Immunology
  47. Hypertensive Disorders of Pregnancy
    Sahar Naderi, Sandra A. Tsai, Abha Khandelwal · 2017 · Current Atherosclerosis Reports
  48. Human placental growth hormone in normal and abnormal fetal growth
    Alexandros Velegrakis, Maria Sfakiotaki, Stavros Sifakis · 2017 · Biomedical Reports
  49. HIF-2α, but not HIF-1α, mediates hypoxia-induced up-regulation of Flt-1 gene expression in placental trophoblasts
    Tadashi Sasagawa, Takeshi Nagamatsu, Kazuki Morita, Nobuko Mimura, Takayuki Iriyama, Tomoyuki Fujii, Masabumi Shibuya · 2018 · Scientific Reports
  50. Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus
    Anna Maria Nuzzo, Domenica Giuffrida, Laura Moretti, Paola Re, Giorgio Grassi, Guido Menato, Alessandro Rolfo · 2021 · Scientific Reports
  51. Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction
    Kelsey McLaughlin, Sebastian Rupert Hobson, Anjana Ravi Chandran, Swati Agrawal, Rory C. Windrim, William Tony Parks, ADRIAN W. BOWMAN, Ulla Sovio, Gordon C. S. Smith, John C. Kingdom · 2021 · American Journal of Obstetrics and Gynecology
  52. Preeclampsia up to date—What’s going on?
    Kanako Bokuda, Atsuhiro Ichihara · 2023 · Hypertension Research
  53. The role of arginine, homoarginine and nitric oxide in pregnancy
    Asma A. Khalil, Lotte Hardman, Pat O’Brien · 2015 · Amino Acids
  54. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia
    Melissa I. March, Carl Geahchan, Julia Wenger, Nandini Raghuraman, Anders Hayden Berg, Hamish R. M. Haddow, Bri Anne McKeon, Rulx Narcisse, Jean Louis David, Jennifer Scott et al. · 2015 · PLoS ONE
  55. Pre-eclampsia has an adverse impact on maternal and fetal health
    Saunders Lin, Dean Leonard, Mary Antonette M. Co, Dhriti Mukhopadhyay, Badri Giri, Lena Perger, Madhava Beeram, Thomas J. Kuehl, Mohammad Nasir Uddin · 2014 · Translational research
  56. Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age
    Tinnakorn Chaiworapongsa, Roberto J. Romero, Francesca Gotsch, Jimmy Espinoza, Jyh Kae Nien, Luis Flavio Gonçalves, Samuel S. Edwin, Yeon Mee Kim, Offer Erez, Juan Pedro Kusanovic et al. · 2008 · The Journal of Maternal-Fetal & Neonatal Medicine
  57. Change in Amniotic Fluid Levels of Multiple Anti-Angiogenic Proteins before Development of Preeclampsia and Intrauterine Growth Restriction
    Chao‐Nin Wang, Shuenn‐Dyh Chang, Hsiu‐Huei Peng, Yun‐Shien Lee, Yao‐Lung Chang, Po‐Jen Cheng, An‐Shine Chao, Tzu‐Hao Wang, Hsin‐Shih Wang · 2010 · The Journal of Clinical Endocrinology & Metabolism
  58. Circulating Endothelial Progenitor Cells During Normal Pregnancy and Pre‐Eclampsia
    Keiichi Matsubara, Emiko Abe, Yuko Matsubara, Kenji Kameda, Masaharu Ito · 2006 · American Journal of Reproductive Immunology
  59. Disruption of gap junctions reduces biomarkers of decidualization and angiogenesis and increases inflammatory mediators in human endometrial stromal cell cultures
    Jie Yu, Juanjuan Wu, Indrani C. Bagchi, Milan K. Bagchi, Neil Sidell, Robert N. Taylor · 2011 · Molecular and Cellular Endocrinology
  60. Prediction and primary prevention of pre-eclampsia
    Shakila Thangaratinam, J. Langenveld, Ben W. Mol, Khalid Saeed Khan · 2011 · Best Practice & Research Clinical Obstetrics & Gynaecology
  61. Maternal plasma soluble fms‐like tyrosine kinase‐1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia
    Ranjit Akolekar, Jader de Jesus Cruz, Jean‐Michel Foidart, Carine Munaut, Kypros H. Nicolaides · 2010 · Prenatal Diagnosis
  62. Predisposing Factors to Abnormal First Trimester Placentation and the Impact on Fetal Outcomes
    Lindsay L. Kroener, Erica T. Wang, Margareta Danuta Pisarska · 2015 · Seminars in Reproductive Medicine
  63. Maternal vitamin D sufficiency and reduced placental gene expression in angiogenic biomarkers related to comorbidities of pregnancy
    Elizabeth V. Schulz, Lori Cruze, Wei Wei, John Gehris, Carol L. Wagner · 2017 · The Journal of Steroid Biochemistry and Molecular Biology
  64. Impact of Preeclampsia on Clinical and Functional Outcomes in Women With Peripartum Cardiomyopathy
    Kathryn J. Lindley, Shayna N. Conner, Alison G. Cahill, Eric L. Novak, Douglas L. Mann · 2017 · Circulation Heart Failure
  65. The serine protease corin in cardiovascular biology and disease
    Qingyu Wu · 2007 · Frontiers in bioscience
  66. Serum Vascular Endothelial Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor 1 Ratio Is an Independent Prognostic Marker in Pancreatic Cancer
    Yu‐Ting Chang, Ming‐Chu Chang, Shu‐Chen Wei, Yu‐Wen Tien, Chiun Hsu, Po‐Chin Liang, Po‐Nien Tsao, I‐Shiow Jan, Jau‐Min Wong · 2008 · Pancreas
  67. Delivery technologies for women’s health applications
    Kelsey L. Swingle, Adele S. Ricciardi, William H. Peranteau, Michael J. Mitchell · 2023 · Nature Reviews Bioengineering
  68. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis
    Piya Chaemsaithong, María M. Gil, Noppadol Chaiyasit, Diana Cuenca-Gómez, Walter Plasencia, Valeria Rollé, Liona C. Poon · 2023 · American Journal of Obstetrics and Gynecology
  69. Impaired endothelial function and elevated levels of pentraxin 3 in early‐onset preeclampsia
    Rangeen Rafik Hamad, Maria Eriksson, Elisabeth Berg, Anders Olof Larsson, Katarina Bremme · 2011 · Acta Obstetricia Et Gynecologica Scandinavica
  70. Distribution of Notch protein members in normal and preeclampsia-complicated placentas
    Luigi Cobellis, Annunziata Mastrogiacomo, Elisabetta Federico, Maria Teresa Schettino, Maria De Falco, Lucrezia Manente, Gabriele Coppola, Marco Torella, Nicola Colacurci, Antonio De Luca · 2007 · Cell and Tissue Research
  71. Emerging New Biomarkers of Preeclampsia
    Srujana Polsani, Elizabeth Phipps, Belinda Jim · 2013 · Advances in Chronic Kidney Disease
  72. Anti-angiogenic factors and pre-eclampsia in type 1 diabetic women
    Yongxin Yu, Alicia Josephine Jenkins, Alison J Nankervis, Kristian Folkvord Hanssen, Hanne Scholz, Tore Henriksen, Bjørg Lorentzen, Torun Clausen, Satish K. Garg, M. Kathryn Menard et al. · 2008 · Diabetologia
  73. Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective
    Nandini Hadker, Suchita Garg, Cory Costanzo, Jeffrey D. Miller, Talia S. Foster, Wim van der Helm, James Creeden · 2010 · Journal of Medical Economics
  74. Mechanism of hypertension and proteinuria during angiogenesis inhibition
    Stephanie Lankhorst, Mariëtte H.W. Kappers, Joep H.M. van Esch, A.H. Jan Danser, Anton H. van den Meiracker · 2012 · Journal of Hypertension
  75. The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia
    Tereza Cindrová‐Davies · 2014 · Frontiers in Pharmacology
  76. Decreased Levels of Folate Receptor‐β and Reduced Numbers of Fetal Macrophages ( H ofbauer Cells) in Placentas from Pregnancies with Severe Pre‐Eclampsia
    Zhonghua Tang, Irina Alexandra Buhimschi, Catalin Sorin Buhimschi, Serkalem Tadesse, Errol R. Norwitz, Tracy Niven‐Fairchild, Se-Te Joseph Huang, Seth M. Guller · 2013 · American Journal of Reproductive Immunology
  77. VEGF Receptor Tyrosine Kinases
    Alberto Álvarez-Aznar, Lars Muhl, Konstantin Gaengel · 2016 · Current topics in developmental biology/Current Topics in Developmental Biology
  78. Statins and Pregnancy
    Édouard Lecarpentier, Olivier Morel, Thierry Fournier, Élisabeth Éléfant, Pascale Chavatte‐Palmer, Vassilis Tsatsaris · 2012 · Drugs
  79. The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term
    David O. Bates, Philip Macmillan, Joseph Manjaly, Yan Qiu, Sarah J. Hudson, Heather S. Bevan, Alyson J. Hunter, PETER W. SOOTHILL, Michael Read, Lucy Frances Donaldson et al. · 2006 · Clinical Science
  80. Autonomic Dysfunction in Preeclampsia: A Systematic Review
    Dalia Yousif, Ioannis Bellos, Ana Isabel Penzlin, Mido Max Hijazi, Ben M. W. Illigens, Alexandra Pintér, Timo Siepmann · 2019 · Frontiers in Neurology
  81. Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study
    Akihide Ohkuchi, Shigeru Saito, Tatsuo Yamamoto, Hisanori Minakami, Hisashi Masuyama, Keiichi Kumasawa, Jun Yoshimatsu, Takeshi Nagamatsu, Angela Dietl, Sonja Grill et al. · 2021 · Hypertension Research
  82. Perspectives on the Use of Placental Growth Factor (PlGF) in the Prediction and Diagnosis of Pre-Eclampsia: Recent Insights and Future Steps
    Lyndsay Creswell, Neil O’Gorman, Kirsten Rebecca Palmer, Fabrício da Silva Costa, Daniel L. Rolnik · 2023 · International Journal of Women s Health
  83. Can the biology of VEGF and haem oxygenases help solve pre-eclampsia?
    Asif Ahmed, Melissa Cudmore · 2009 · Biochemical Society Transactions
  84. Comprehensive Maternal Serum Proteomic Profiles of Preclinical and Clinical Preeclampsia
    Juha P. Rasanen, Anna Iida Girsen, Xinfang Lu, Jodi Lapidus, Melissa S. Standley, Ashok P. Reddy, Surendra Dasari, Archana Thomas, Thomas Jacob, Anneli M. Pouta et al. · 2010 · Journal of Proteome Research
  85. Women and Transplantation: Fertility, Sexuality, Pregnancy, Contraception
    Michelle A. Josephson, Dianne B. McKay · 2013 · Advances in Chronic Kidney Disease
  86. Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia
    Elizabeth Ramsey Unal, Christopher Robinson, Donna Johnson, Eugene Chang · 2007 · American Journal of Obstetrics and Gynecology
  87. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome
    Brett C. Young, Richard J. Levine, Saira Salahuddin, Cong Qian, Kee-Hak Lim, S. Ananth Karumanchi, Sarosh Rana · 2009 · The Journal of Maternal-Fetal & Neonatal Medicine
  88. Does soluble fms-like tyrosine kinase-1 regulate placental invasion? Insight from the invasive placenta
    Kerry Ann McMahon, S. Ananth Karumanchi, Isaac Ely Stillman, Peter Cummings, Dorothy L. Patton, Thomas R. Easterling · 2013 · American Journal of Obstetrics and Gynecology
  89. Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia
    Sarosh Rana, Ana Sofia Cerdeira, Julia Wenger, Saira Salahuddin, Kee-Hak Lim, Steven J. Ralston, Ravi Thadhani, S. Ananth Karumanchi · 2012 · PLoS ONE
  90. The Multiple Roles of EG-VEGF/PROK1 in Normal and Pathological Placental Angiogenesis
    Nadia Alfaidy, P. Hoffmann, Houssine Boufettal, Naïma Samouh, Touria Aboussaouira, Mohamed Benharouga, Jean‐Jacques Feige, Sophie Brouillet · 2014 · BioMed Research International
  91. Decreased expression of apelin in placentas from severe pre-eclampsia patients
    Hiromi Inuzuka, Haruki Nishizawa, Ayaka Inagaki, Machiko Suzuki, Sayuri Ota, Hironori Miyamura, Jun Miyazaki, Takao Sekiya, Hiroki Kurahashi, Yasuhiro Udagawa · 2013 · Hypertension in Pregnancy
  92. Preeclampsia and small-for-gestational age are associated with decreased concentrations of a factor involved in angiogenesis: Soluble Tie-2
    Francesca Gotsch, Roberto J. Romero, Juan Pedro Kusanovic, Tinnakorn Chaiworapongsa, Michael Dombrowski, Offer Erez, Nándor Gábor Than, Shali Mazaki‐Tovi, Pooja Mittal, Jimmy Espinoza et al. · 2008 · The Journal of Maternal-Fetal & Neonatal Medicine
  93. Biomarker for hypertension-preeclampsia: are we close yet?
    Baha M. Sibai · 2007 · American Journal of Obstetrics and Gynecology
  94. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period
    Loren N. Petrozella, Mala Mahendroo, Brenda C. Timmons, Scott W. Roberts, Donald D. McIntire, James M. Alexander · 2012 · American Journal of Obstetrics and Gynecology
  95. ELABELA, as a potential diagnostic biomarker of preeclampsia, regulates abnormally shallow placentation via APJ
    Lu Zhou, Hang Sun, Ran Cheng, Xiujun Fan, Shanshan Lai, Cheng Deng · 2019 · American Journal of Physiology-Endocrinology and Metabolism
  96. Aspirin Discontinuation at 24 to 28 Weeks’ Gestation in Pregnancies at High Risk of Preterm Preeclampsia
    Manel Mendoza, Erika Bonacina, Pablo García‐Manau, Monica López, Sara Caamiña, Àngels Vives, Eva López‐Quesada, Marta Ricart, Anna Maroto, Laura de Mingo et al. · 2023 · JAMA
  97. Urinary tract infection during pregnancy, angiogenic factor profiles, and risk of preeclampsia
    Sarah Rae Easter, David E. Cantonwine, Chloe Zera, Kee-Hak Lim, Samuel I. Parry, Thomas Frederick McElrath · 2015 · American Journal of Obstetrics and Gynecology
  98. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application
    Olav Lapaire, Andrew H. Shennan, Holger Stepan · 2010 · European Journal of Obstetrics & Gynecology and Reproductive Biology
  99. SFlt-1 Elevates Blood Pressure by Augmenting Endothelin-1-Mediated Vasoconstriction in Mice
    Fouad Amraoui, Léon J. A. Spijkers, Hajar Hassani Lahsinoui, Liffert Vogt, Joris van der Post, Stephan L.M. Peters, Gijs Afink, Carrie Ris‐Stalpers, Bert‐Jan H. van den Born · 2014 · PLoS ONE
  100. Controlled Direct Effects of Preeclampsia on Neonatal Health After Accounting for Mediation by Preterm Birth
    Pauline Mendola, Sunni L. Mumford, Tuija I. Männistö, Alexander M. Holston, Uma M. Reddy, S. Katherine Laughon · 2014 · Epidemiology